7.3 Common POCT Procedures (Glucose, Coagulation, Hemoglobin/Hematocrit)

Common POCT Procedures (Glucose, Coagulation, Hemoglobin/Hematocrit)

Point-of-care testing encompasses a diverse spectrum of CLIA-waived diagnostic procedures performed across inpatient wards, emergency rooms, surgical suites, outpatient clinics, and community screening events. A phlebotomist performing bedside assays must master the analytical principles, step-by-step procedural techniques, specimen collection mandates, and critical value reporting protocols for common POCT assays, including blood glucose, coagulation parameters, hematology screens, cardiac markers, urine chemistry dipsticks, and rapid lateral-flow immunochromatographic tests.

Bedside Blood Glucose Monitoring

Bedside blood glucose testing using portable glucometers is the most frequently executed POCT procedure in clinical healthcare. It provides immediate evaluation of glycemic control in diabetic patients, detects acute hypoglycemia or hyperglycemia, and guides insulin administration.

Step-by-Step Glucometer Procedure

1. Patient Verification & Prep: Verify patient identity using 3-way matching. Cleanse the dermal puncture site (lateral planter heel for infants; sides of the 3rd or 4th fingertip for adults) with 70% isopropyl alcohol and allow to air dry completely.
2. Dermal Puncture: Perform a puncture using a sterile single-use retractable safety lancet perpendicular to the fingerprint whorls.
3. Wipe Away First Drop: Mandatory Step! Wipe away the very first drop of blood with a sterile dry gauze pad. The first drop contains interstitial tissue fluid and residual alcohol, which dilute the sample and cause falsely decreased or erratic glucose readings.
4. Sample Application: Allow a large, rounded second drop of blood to form. Touch the test strip target area or capillary tip directly to the blood drop. Do not scrape the skin or smear the blood.
5. Result Interpretation & Documentation: Read the digital display, record the value immediately in the chart/meter, and dispose of the lancet into a biohazard sharps container.

Critical Value Thresholds & Reporting Workflows

Glucometer readings requiring immediate clinical notification (critical values) are defined by facility policy but typically encompass:

• Hypoglycemia Threshold: Blood glucose <50 mg/dL (or <70 mg/dL in symptomatic patients). Requires immediate verbal alert to the primary nurse/physician and administration of fast-acting oral carbohydrates or IV dextrose.
• Hyperglycemia Threshold: Blood glucose >400 mg/dL (or display reading "HI"). Indicates severe hyperosmolar nonketotic state or diabetic ketoacidosis risk, requiring urgent medical intervention.

POCT Coagulation Testing

Bedside coagulation testing monitors hemostatic function and therapeutic anticoagulation without the delays associated with central laboratory plasma processing.

Prothrombin Time / International Normalized Ratio (PT/INR)

Portable PT/INR monitors (e.g., CoaguChek system) measure the extrinsic coagulation pathway using capillary blood obtained via dermal puncture.

• Clinical Indication: Monitoring outpatient oral anticoagulant therapy (Warfarin / Coumadin).
• Target INR Ranges: Standard therapeutic INR is typically 2.0 to 3.0 (or 2.5 to 3.5 for mechanical heart valves). An INR >4.5 represents a critical bleeding risk requiring immediate physician notification.

Activated Clotting Time (ACT)

ACT analyzers evaluate high-dose heparin anticoagulation in real time using whole blood specimens.

• Clinical Setting: Executed exclusively in cardiac catheterization laboratories, open-heart surgical suites, and hemodialysis units.
• Clinical Purpose: Standard partial thromboplastin time (aPTT) tests clot too slowly or become unmeasurable at very high heparin doses. ACT monitors heparin suppression of clot formation during cardiopulmonary bypass to prevent intravascular thrombosis.

POCT Hemoglobin and Hematocrit Testing

Hemoglobin (Hb) and Hematocrit (Hct) assays evaluate oxygen-carrying capacity, screen for anemia, and monitor acute blood loss.

HemoCue Photometer Method

The HemoCue system utilizes a specialized microcuvette coated with dry reagents that draw capillary or venous blood by capillary action. The microcuvette is inserted into a portable photometer that measures azidemethemoglobin absorbance at dual wavelengths, displaying hemoglobin concentration in g/dL within seconds.

Microhematocrit Centrifugation

Microhematocrit testing measures the volume percentage of red blood cells in whole blood (packed cell volume):

1. Plain or heparinized capillary tubes are filled 3/4 full with whole blood.
2. One end of the tube is sealed with clay sealant plug.
3. Tubes are spun in a microhematocrit centrifuge at 11,000–12,000 RPM for 3 to 5 minutes.
4. The spun tube is placed on a microhematocrit reading card to determine the red cell percentage (normal adult male: 42%–52%; female: 37%–47%).

Rapid Cardiac Marker Screening

Point-of-care cardiac marker cassette tests provide qualitative or quantitative measurement of Cardiac Troponin I (cTnI) and Troponin T (cTnT) from whole blood or plasma. Troponins are regulatory proteins released into circulation following myocardial cell necrosis. Bedside troponin tests allow emergency physicians to rapidly triage patients presenting with chest pain for acute myocardial infarction (AMI).

Urine Dipstick Chemical Screening & Rapid Visual Assays

Urine dipstick tests feature plastic strips containing up to ten separate chemical reagent pads that undergo color changes upon contact with urine parameters.

Rapid Immunochromatographic Assays

Rapid visual cassette tests rely on lateral flow immunoassay technology:

• Urine Pregnancy Testing (hCG): Detects human chorionic gonadotropin secreted by the developing placenta. Requires first-morning voided urine for maximum concentration.
• Rapid Strep A Throat Swab: Detects Group A Streptococcus antigen from pharyngeal swabs.
• Rapid Influenza A/B: Detects viral nucleoprotein antigens from nasopharyngeal swabs.

Comparative Summary of Common Waived POCT Assays

Clinical Scenario: Identifying Hypoglycemia & Managing Critical Values

A phlebotomist is called to the neurology step-down unit to perform a routine pre-prandial blood glucose check on an 82-year-old female patient with insulin-dependent type 2 diabetes.

The phlebotomist performs a fingerstick, wipes away the first drop of blood, and applies the second drop to the glucometer strip. The meter beeps and displays a result of 42 mg/dL, accompanied by a flashing "CRITICAL LOW" indicator.

Recognizing that 42 mg/dL is below the facility's critical threshold of 50 mg/dL, the phlebotomist immediately verifies that the patient is conscious but reporting mild dizziness. Following the hospital's critical value protocol, the phlebotomist immediately alerts the assigned bedside nurse in person, provides the patient's name, DOB, location, and exact glucose value, and documents the nurse's name, time of verbal notification, and read-back confirmation directly into the POCT record system. The nurse promptly administers 15 grams of oral fast-acting glucose gel, preventing severe hypoglycemic loss of consciousness.

Common Traps & Exam Pitfalls

• Trap 1: Squeezing (Milking) the Fingerstick Site: Vigorously squeezing or milking the dermal puncture site forces interstitial tissue fluid into the blood sample, causing hemolysis and falsely diluting glucose and hemoglobin results.
• Trap 2: Misinterpreting Urine Dipstick Reaction Times: Reading all pads on a urine dipstick simultaneously at 2 minutes. Parameters like glucose must be read at 30 seconds; reading at 2 minutes results in false-positive readings due to reagent over-development.
• Trap 3: Using Diluted Urine for Pregnancy Tests: Performing a POCT urine hCG test on a highly diluted afternoon urine specimen with low specific gravity, which can produce a false-negative result in early pregnancy. First-morning urine is mandatory.